Socs1 Deficiency Enhances Hepatic Insulin Signaling
Open Access
- 1 September 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (36) , 31516-31521
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- AMP-activated Protein Kinase Is Required for the Lipid-lowering Effect of Metformin in Insulin-resistant Human HepG2 CellsJournal of Biological Chemistry, 2004
- Severe Pancreatitis with Exocrine Destruction and Increased Islet Neogenesis in Mice with Suppressor of Cytokine Signaling-1 DeficiencyThe American Journal of Pathology, 2004
- AMP-activated protein kinase, super metabolic regulatorBiochemical Society Transactions, 2003
- SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2Journal of Biological Chemistry, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin ReceptorJournal of Biological Chemistry, 2001
- Contrasting Effects of IRS-1 Versus IRS-2 Gene Disruption on Carbohydrate and Lipid Metabolism in VivoJournal of Biological Chemistry, 2000
- Loss of Insulin Signaling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic DysfunctionMolecular Cell, 2000
- Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2Journal of Clinical Investigation, 2000
- SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this CytokineCell, 1999